Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1

Biochim Biophys Acta. 2009 Jul;1787(7):947-54. doi: 10.1016/j.bbabio.2009.02.001. Epub 2009 Feb 11.

Abstract

Human T-cell leukemia virus type-1 (HTLV-1) expresses an 87-amino acid protein named p13 that is targeted to the inner mitochondrial membrane. Previous studies showed that a synthetic peptide spanning an alpha helical domain of p13 alters mitochondrial membrane permeability to cations, resulting in swelling. The present study examined the effects of full-length p13 on isolated, energized mitochondria. Results demonstrated that p13 triggers an inward K(+) current that leads to mitochondrial swelling and confers a crescent-like morphology distinct from that caused by opening of the permeability transition pore. p13 also induces depolarization, with a matching increase in respiratory chain activity, and augments production of reactive oxygen species (ROS). These effects require an intact alpha helical domain and strictly depend on the presence of K(+) in the assay medium. The effects of p13 on ROS are mimicked by the K(+) ionophore valinomycin, while the protonophore FCCP decreases ROS, indicating that depolarization induced by K(+) vs. H(+) currents has different effects on mitochondrial ROS production, possibly because of their opposite effects on matrix pH (alkalinization and acidification, respectively). The downstream consequences of p13-induced mitochondrial K(+) permeability are likely to have an important influence on the redox state and turnover of HTLV-1-infected cells.

MeSH terms

  • Calcium / pharmacology
  • Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / pharmacology
  • Human T-lymphotropic virus 1* / genetics
  • Human T-lymphotropic virus 1* / metabolism
  • Humans
  • Ionophores / pharmacology
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria / ultrastructure
  • Mitochondrial Membrane Transport Proteins / metabolism*
  • Mitochondrial Permeability Transition Pore
  • Mitochondrial Swelling / drug effects
  • Models, Biological
  • Permeability
  • Potassium / metabolism*
  • Potassium Channels / metabolism
  • Reactive Oxygen Species / metabolism*
  • Valinomycin / pharmacology

Substances

  • Ionophores
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Potassium Channels
  • Reactive Oxygen Species
  • Valinomycin
  • Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
  • Potassium
  • Calcium